Evidence map›Paper›PMID 26808574›Full record

ArticlePloS one2016

IL-10 Accelerates Re-Endothelialization and Inhibits Post-Injury Intimal Hyperplasia following Carotid Artery Denudation.

Suresh K Verma, Venkata Naga Srikanth Garikipati, Prasanna Krishnamurthy, Mohsin Khan, Tina Thorne, Gangjian Qin, Douglas W Losordo, Raj Kishore

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Treg cells in atherosclerosis.Molecular biology reports · 2021
    Review
  8. tRNA-derived fragments tRFMolecular therapy. Nucleic acids · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Suresh K VermaCenter for Translational Medicine, Temple University, Philadelphia, Pennsylvania United States of America.
Venkata Naga Srikanth GarikipatiCenter for Translational Medicine, Temple University, Philadelphia, Pennsylvania United States of America.
Prasanna KrishnamurthyDepartment of Cardiovascular Science, Houston Methodist Research Institute, Houston, Texas, United States of America.
Mohsin KhanCenter for Translational Medicine, Temple University, Philadelphia, Pennsylvania United States of America.
Tina ThorneFeinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
Gangjian QinFeinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
Douglas W LosordoFeinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
Raj KishoreCenter for Translational Medicine, Temple University, Philadelphia, Pennsylvania United States of America.
Temple University · USNorthwestern University · USHouston Methodist · US

Funding

Small Animal Surgery and HistologyP01HL108795 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LOSORDO, DOUGLAS W · 2011 to 2015
$10.7M
TNF mRNA stability and restenosisR01HL091983 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KISHORE, RAJ · 2009 to 2022
$5.3M
Therapeutic Angiogenesis in Vascular Medicine IVR01HL053354 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KISHORE, RAJ · 1995 to 2015
$4.2M
microRNA mediation of Endothelial Progenitor Cell function in Myocardial IchemiaR01HL116729 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KRISHNAMURTHY, PRASANNA · 2013 to 2017
$1.9M
Pluripotent cell-derived exosomes as mediators of myocardial regenerationR01HL126186 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KISHORE, RAJ · 2015 to 2018
$1.6M
Effect of chronic alcohol on ischemic injury and endothelial cellsR01HL105597 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI KISHORE, RAJ · 2011 to 2014
$1.5M
THERAPEUTIC ANGIOGENESIS IN VASCULAR MEDICINE IIR37HL053354 · NHLBI · CARITAS ST. ELIZABETH'S MEDICAL CENTER · PI ISNER, JEFFREY · 2000 to 2001
$726k
American Heart Association-American Stroke Association 14SDG20480104NHLBI NIH HHS HL091983NHLBI NIH HHS HL105597NHLBI NIH HHS HL108795NHLBI NIH HHS HL126186NHLBI NIH HHS P01 HL108795NHLBI NIH HHS R01 HL053354NHLBI NIH HHS R01 HL091983NHLBI NIH HHS R01 HL105597NHLBI NIH HHS R01 HL116729NHLBI NIH HHS R01 HL126186NHLBI NIH HHS R37 HL053354
6 · The paper itself

Abstract

The role of inflammation on atherosclerosis and restenosis is well established. Restenosis is thought to be a complex response to injury, which includes early thrombus formation, acute inflammation and neo-intimal growth. Inflammatory cells are likely contributors in the host response to vascular injury, via cytokines and chemokines secretion, including TNF-alpha (TNF). We have previously shown that IL-10 inhibits TNF and other inflammatory mediators produced in response to cardiovascular injuries. The specific effect of IL-10 on endothelial cell (ECs) biology is not well elucidated. Here we report that in a mouse model of carotid denudation, IL-10 knock-out mice (IL-10KO) displayed significantly delayed Re-endothelialization and enhanced neo-intimal growth compared to their WT counterparts. Exogenous recombinant IL-10 treatment dramatically blunted the neo-intimal thickening while significantly accelerating the recovery of the injured endothelium in WT mice. In vitro, IL-10 inhibited negative effects of TNF on ECs proliferation, ECs cell cycle, ECs-monocyte adhesion and ECs apoptosis. Furthermore, IL-10 treatment attenuated TNF-induced smooth muscle cells proliferation. Our data suggest that IL-10 differentially regulate endothelial and vascular smooth cells proliferation and function and thus inhibits neo-intimal hyperplasia. Thus, these results may provide insights necessary to develop new therapeutic strategies to limit vascular restenosis during percutaneous coronary intervention (PCI) in the clinics.

Indexed as

AnimalsCarotid ArteriesCell AdhesionCell Cycle CheckpointsCell ProliferationEndothelium, VascularHyperplasiaInterleukin-10MiceMice, Inbred C57BLMice, KnockoutTumor Necrosis Factor-alphaTunica IntimaInterleukin-10Tumor Necrosis Factor-alpha

Identifiers

PMID26808574
PMCPMC4725953
OpenAlexW2267902904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.